NLRP3 inflammasome priming and activation in cholestatic liver injury via the sphingosine 1-phosphate/S1P receptor 2/Gα(12/13)/MAPK signaling pathway (original) (raw)
References
Li Y, Tang R, Leung PSC, Gershwin ME, Ma X (2017) Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases. Autoimmun Rev 16(9):885–896 ArticleCASPubMed Google Scholar
Vilas-Boas V, Gijbels E, Jonckheer J, De Waele E, Vinken M (2020) Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition. Environ Int 136:105422 ArticleCASPubMed Google Scholar
Woolbright BL (2020) Inflammation: cause or consequence of chronic cholestatic liver injury. Food Chem Toxicol 137:111133 ArticleCASPubMed Google Scholar
Gomez-Munoz A, Presa N, Gomez-Larrauri A, Rivera IG, Trueba M, Ordonez M (2016) Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate. Prog Lipid Res 61:51–62 ArticleCASPubMed Google Scholar
Ksiazek M, Chacinska M, Chabowski A, Baranowski M (2015) Sources, metabolism, and regulation of circulating sphingosine-1-phosphate. J Lipid Res 56(7):1271–1281 ArticleCASPubMedPubMed Central Google Scholar
Li C, Zheng S, You H, Liu X, Lin M, Yang L, Li L (2011) Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility. J Hepatol 54(6):1205–1213 ArticleCASPubMed Google Scholar
Yang L, Yue S, Yang L, Liu X, Han Z, Zhang Y, Li L (2013) Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis. J Hepatol 59(1):114–123 ArticleCASPubMed Google Scholar
Zhao S, Adebiyi MG, Zhang Y, Couturier JP, Fan X, Zhang H, Kellems RE, Lewis DE, Xia Y (2018) Sphingosine-1-phosphate receptor 1 mediates elevated IL-6 signaling to promote chronic inflammation and multitissue damage in sickle cell disease. FASEB J 32(5):2855–2865 ArticlePubMedPubMed Central Google Scholar
Gaire BP, Song MR, Choi JW (2018) Sphingosine 1-phosphate receptor subtype 3 (S1P3) contributes to brain injury after transient focal cerebral ischemia via modulating microglial activation and their M1 polarization. J Neuroinflammation 15(1):284 ArticleCASPubMedPubMed Central Google Scholar
Yang L, Han Z, Tian L, Mai P, Zhang Y, Wang L, Li L (2015) Sphingosine 1-phosphate receptor 2 and 3 mediate bone marrow-derived monocyte/macrophage motility in cholestatic liver injury in mice. Sci Rep 5:13423 ArticlePubMedPubMed Central Google Scholar
Yang J, Yang L, Tian L, Ji X, Yang L, Li L (2018) Sphingosine 1-phosphate (S1P)/S1P receptor2/3 axis promotes inflammatory M1 polarization of bone marrow-derived monocyte/macrophage via G(alpha)i/o/PI3K/JNK pathway. Cell Physiol Biochem 49(5):1677–1693 ArticleCASPubMed Google Scholar
Mantovani A, Dinarello CA, Molgora M, Garlanda C (2019) Interleukin-1 and related cytokines in the regulation of inflammation and immunity. Immunity 50(4):778–795 ArticleCASPubMedPubMed Central Google Scholar
El Kasmi KC, Vue PM, Anderson AL, Devereaux MW, Ghosh S, Balasubramaniyan N, Fillon SA, Dahrenmoeller C, Allawzi A, Woods C, McKenna S, Wright CJ, Johnson L, D'Alessandro A, Reisz JA, Nozik-Grayck E, Suchy FJ, Sokol RJ (2018) Macrophage-derived IL-1β/NF-κB signaling mediates parenteral nutrition-associated cholestasis. Nat Commun 9(1):1393 ArticlePubMedPubMed Central Google Scholar
Meier RPH, Meyer J, Montanari E, Lacotte S, Balaphas A, Muller YD, Clément S, Negro F, Toso C, Morel P, Buhler LH (2019) Interleukin-1 receptor antagonist modulates liver inflammation and fibrosis in mice in a model-dependent manner. Int J Mol Sci 20(6). https://doi.org/10.3390/ijms20061295
Awad F, Assrawi E, Louvrier C, Jumeau C, Georgin-Lavialle S, Grateau G, Amselem S, Giurgea I, Karabina SA (2018) Inflammasome biology, molecular pathology and therapeutic implications. Pharmacol Ther 187:133–149 ArticleCASPubMed Google Scholar
Mridha AR, Wree A, Robertson AAB, Yeh MM, Johnson CD, Van Rooyen DM, Haczeyni F, Teoh NC, Savard C, Ioannou GN, Masters SL, Schroder K, Cooper MA, Feldstein AE, Farrell GC (2017) NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol 66(5):1037–1046 ArticleCASPubMedPubMed Central Google Scholar
Cai SY, Ge M, Mennone A, Hoque R, Ouyang X, Boyer JL (2020) Inflammasome is activated in the liver of Cholestatic patients and aggravates hepatic injury in bile duct-ligated mouse. Cell Mol Gastroenterol Hepatol 9(4):679–688 ArticlePubMed Google Scholar
Ning ZW, Luo XY, Wang GZ, Li Y, Pan MX, Yang RQ, Ling XG, Huang S, Ma XX, Jin SY, Wang D, Li X (2017) MicroRNA-21 mediates angiotensin II-induced liver fibrosis by activating NLRP3 inflammasome/IL-1β Axis via targeting Smad7 and Spry1. Antioxid Redox Signal 27(1):1–20 ArticleCASPubMedPubMed Central Google Scholar
Wree A, McGeough MD, Pena CA, Schlattjan M, Li H, Inzaugarat ME, Messer K, Canbay A, Hoffman HM, Feldstein AE (2014) NLRP3 inflammasome activation is required for fibrosis development in NAFLD. J Mol Med (Berlin, Germany) 92(10):1069–1082 ArticleCAS Google Scholar
Jin Y, Li C, Xu D, Zhu J, Wei S, Zhong A, Sheng M, Duarte S, Coito AJ, Busuttil RW, Xia Q, Kupiec-Weglinski JW, Ke B (2019) Jagged1-mediated myeloid Notch1 signaling activates HSF1/snail and controls NLRP3 inflammasome activation in liver inflammatory injury. Cell Mol Immunol 17:1245–1256 ArticlePubMedPubMed Central Google Scholar
Zhang S, Jiang L, Hu H, Wang H, Wang X, Jiang J, Ma Y, Yang J, Hou Y, Xie D, Zhang Q (2020) Pretreatment of exosomes derived from hUCMSCs with TNF-alpha ameliorates acute liver failure by inhibiting the activation of NLRP3 in macrophage. Life Sci 246:117401 ArticleCASPubMed Google Scholar
Zhang WJ, Fang ZM, Liu WQ (2019) NLRP3 inflammasome activation from Kupffer cells is involved in liver fibrosis of Schistosoma japonicum-infected mice via NF-kappaB. Parasit Vectors 12(1):29 ArticlePubMedPubMed Central Google Scholar
Li C, Kong Y, Wang H, Wang S, Yu H, Liu X, Yang L, Jiang X, Li L, Li L (2009) Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J Hepatol 50(6):1174–1183 ArticleCASPubMed Google Scholar
Tilg H, Moschen AR, Szabo G (2016) Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatology (Baltimore, Md) 64(3):955–965 ArticleCAS Google Scholar
Boaru SG, Borkham-Kamphorst E, Tihaa L, Haas U, Weiskirchen R (2012) Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease. J Inflamm (London, England) 9(1):49 ArticleCAS Google Scholar
van der Heide D, Weiskirchen R, Bansal R (2019) Therapeutic targeting of hepatic macrophages for the treatment of liver diseases. Front Immunol 10:2852 ArticlePubMedPubMed Central Google Scholar
Tacke F (2017) Targeting hepatic macrophages to treat liver diseases. J Hepatol 66(6):1300–1312 ArticleCASPubMed Google Scholar
Takabe K, Paugh SW, Milstien S, Spiegel S (2008) “Inside-out” signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev 60(2):181–195 ArticleCASPubMed Google Scholar
Alyaseer AAA, de Lima MHS, Braga TT (2020) The role of NLRP3 inflammasome activation in the epithelial to mesenchymal transition process during the fibrosis. Front Immunol 11:883 ArticleCASPubMedPubMed Central Google Scholar
McMillin M, Frampton G, Grant S, Khan S, Diocares J, Petrescu A, Wyatt A, Kain J, Jefferson B, DeMorrow S (2017) Bile acid-mediated sphingosine-1-phosphate receptor 2 signaling promotes neuroinflammation during hepatic encephalopathy in mice. Front Cell Neurosci 11:191 ArticlePubMedPubMed Central Google Scholar
Zhao S, Gong Z, Du X, Tian C, Wang L, Zhou J, Xu C, Chen Y, Cai W, Wu J (2018) Deoxycholic acid-mediated sphingosine-1-phosphate receptor 2 signaling exacerbates DSS-induced colitis through promoting cathepsin B release. J Immunol Res 2018:2481418 ArticlePubMedPubMed Central Google Scholar
Yan T, Wang H, Cao L, Wang Q, Takahashi S, Yagai T, Li G, Krausz KW, Wang G, Gonzalez FJ, Hao H (2018) Glycyrrhizin alleviates nonalcoholic Steatohepatitis via modulating bile acids and meta-inflammation. Drug Metab Dispos 46(9):1310–1319 ArticleCASPubMedPubMed Central Google Scholar
Weichand B, Popp R, Dziumbla S, Mora J, Strack E, Elwakeel E, Frank AC, Scholich K, Pierre S, Syed SN, Olesch C, Ringleb J, Oren B, Doring C, Savai R, Jung M, von Knethen A, Levkau B, Fleming I, Weigert A, Brune B (2017) S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1beta. J Exp Med 214(9):2695–2713 ArticleCASPubMedPubMed Central Google Scholar
Gu JL, Muller S, Mancino V, Offermanns S, Simon MI (2002) Interaction of G alpha(12) with G alpha(13) and G alpha(q) signaling pathways. Proc Natl Acad Sci U S A 99(14):9352–9357 ArticleCASPubMedPubMed Central Google Scholar
Kim KM, Han CY, Kim JY, Cho SS, Kim YS, Koo JH, Lee JM, Lim SC, Kang KW, Kim JS, Hwang SJ, Ki SH, Kim SG (2018) Galpha12 overexpression induced by miR-16 dysregulation contributes to liver fibrosis by promoting autophagy in hepatic stellate cells. J Hepatol 68(3):493–504 ArticleCASPubMedPubMed Central Google Scholar
Kaffe E, Katsifa A, Xylourgidis N, Ninou I, Zannikou M, Harokopos V, Foka P, Dimitriadis A, Evangelou K, Moulas AN, Georgopoulou U, Gorgoulis VG, Dalekos GN, Aidinis V (2017) Hepatocyte autotaxin expression promotes liver fibrosis and cancer. Hepatology (Baltimore, Md) 65(4):1369–1383 ArticleCAS Google Scholar
Bataller R, Sancho-Bru P, Gines P, Lora JM, Al-Garawi A, Sole M, Colmenero J, Nicolas JM, Jimenez W, Weich N, Gutierrez-Ramos JC, Arroyo V, Rodes J (2003) Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 125(1):117–125 ArticleCASPubMed Google Scholar
Wang C, Hockerman S, Jacobsen EJ, Alippe Y, Selness SR, Hope HR, Hirsch JL, Mnich SJ, Saabye MJ, Hood WF, Bonar SL, Abu-Amer Y, Haimovich A, Hoffman HM, Monahan JB, Mbalaviele G (2018) Selective inhibition of the p38alpha MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signals. J Exp Med 215(5):1315–1325 ArticleCASPubMedPubMed Central Google Scholar
Li Z, Zhao F, Cao Y, Zhang J, Shi P, Sun X, Zhang F, Tong L (2018) DHA attenuates hepatic ischemia reperfusion injury by inhibiting pyroptosis and activating PI3K/Akt pathway. Eur J Pharmacol 835:1–10 ArticleCASPubMed Google Scholar
Song N, Liu ZS, Xue W, Bai ZF, Wang QY, Dai J, Liu X, Huang YJ, Cai H, Zhan XY, Han QY, Wang H, Chen Y, Li HY, Li AL, Zhang XM, Zhou T, Li T (2017) NLRP3 phosphorylation is an essential priming event for inflammasome activation. Mol Cell 68(1):185–197.e186 ArticleCASPubMed Google Scholar
Wang F, Okamoto Y, Inoki I, Yoshioka K, Du W, Qi X, Takuwa N, Gonda K, Yamamoto Y, Ohkawa R, Nishiuchi T, Sugimoto N, Yatomi Y, Mitsumori K, Asano M, Kinoshita M, Takuwa Y (2010) Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice. J Clin Invest 120(11):3979–3995 ArticleCASPubMedPubMed Central Google Scholar